{"id":5952,"date":"2025-03-16T15:31:39","date_gmt":"2025-03-16T12:31:39","guid":{"rendered":"https:\/\/jordan-cardiac.org\/?p=5952"},"modified":"2025-03-16T15:31:39","modified_gmt":"2025-03-16T12:31:39","slug":"patient-discharged-with-total-artificial-heart-for-the-first-time-105-days-before-transplant","status":"publish","type":"post","link":"https:\/\/jordan-cardiac.org\/en\/patient-discharged-with-total-artificial-heart-for-the-first-time-105-days-before-transplant\/","title":{"rendered":"Patient Discharged with Total Artificial Heart for the First Time\u2014105 Days Before Transplant"},"content":{"rendered":"
Patient Discharged with Total Artificial Heart for the First Time\u2014105 Days Before Transplant<\/div>\n
<\/div>\n
Source: March 13, 2025 | This article was highlighted by an AHA update.<\/div>\n
<\/span>1. <\/span>First Patient Discharged with a Total Artificial Heart (TAH)<\/div>\n
<\/span>\u2022 <\/span>A patient in Australia became the first in the world to be discharged while supported by BiVACOR\u2019s total artificial heart (TAH).<\/div>\n
<\/span>\u2022 <\/span>The patient lived with the device for 105 days before successfully receiving a heart transplant on March 6, 2025.<\/div>\n
<\/span>2. <\/span>Significance of the Procedure<\/div>\n
<\/span>\u2022 <\/span>The implantation was performed at St. Vincent\u2019s Hospital Sydney, marking the first use of BiVACOR\u2019s TAH outside the U.S.<\/div>\n
<\/span>\u2022 <\/span>Traditionally, patients with TAH remain hospitalized while awaiting a donor heart, but this patient\u2019s discharge represents a major milestone in patient mobility and quality of life.<\/div>\n
<\/span>3. <\/span>Statement from BiVACOR\u2019s Founder<\/div>\n
<\/span>\u2022 <\/span>Daniel Timms, PhD, BiVACOR\u2019s founder and CTO, highlighted that the success of this case demonstrates the safety and reliability of the BiVACOR TAH.<\/div>\n
<\/span>\u2022 <\/span>The patient was able to celebrate his birthday, Christmas, and New Year with his family while free from heart failure symptoms.<\/div>\n
<\/span>4. <\/span>Overview of BiVACOR\u2019s TAH Technology<\/div>\n
<\/span>\u2022 <\/span>Designed as a bridge to transplant for patients with end-stage heart failure.<\/div>\n
<\/span>\u2022 <\/span>Made of titanium, about the size of an adult\u2019s fist.<\/div>\n
<\/span>\u2022 <\/span>Unlike traditional artificial hearts, it has no valves or flexing ventricle chambers\u2014its only moving part is a magnetically suspended double-sided centrifugal pump impeller.<\/div>\n
<\/span>5. <\/span>Regulatory Progress<\/div>\n
<\/span>\u2022 <\/span>In December 2024, the U.S. Food and Drug Administration (FDA) reviewed early data from the first five patients implanted with BiVACOR\u2019s TAH.<\/div>\n
<\/span>\u2022 <\/span>The FDA approved expanding the ongoing feasibility study to 15 additional patients.<\/div>\n
<\/div>\n
This groundbreaking case demonstrates significant advancements in total artificial heart technology, improving patient mobility and extending survival while awaiting transplantation.<\/div>\n","protected":false},"excerpt":{"rendered":"

Patient Discharged with Total Artificial Heart for the First Time\u2014105 Days Before Transplant Source: March 13, 2025 | This article was highlighted by an AHA update. 1. First Patient Discharged with a Total Artificial Heart (TAH) \u2022 A patient in Australia became the first in the world to be discharged while supported by BiVACOR\u2019s total […]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-5952","post","type-post","status-publish","format-standard","hentry","category-uncategorized"],"_links":{"self":[{"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/posts\/5952","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/comments?post=5952"}],"version-history":[{"count":1,"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/posts\/5952\/revisions"}],"predecessor-version":[{"id":5953,"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/posts\/5952\/revisions\/5953"}],"wp:attachment":[{"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/media?parent=5952"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/categories?post=5952"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/tags?post=5952"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}